November Allergy Action Awards Gala Update

November Allergy Action Awards Gala Update

Join us for our first annual Rochester Community Action Awards event! It will be held Thursday, November 15 from 6-9 p.m. at ARTISANworks on Blossom Road in Rochester. Read here to find out who the first well-deserved recipients of the awards will be. We could really use your help to find sponsors for the event and items for a silent auction. Please contact Patrick Morris at This email address is being protected from spambots. You need JavaScript enabled to view it. if you have any suggestions.

We sincerely thank you and will look forward to seeing you on November 15!

GALA Awards Event Vertical logo

October 17th, 2018
Allergy Advocacy Association’s
Rochester Community Action Awards
First Annual Fundraising Gala

This event will honor leaders of our community who have made invaluable contributions to advocacy, management and research of life-threatening allergies.

Thursday, November 15, 2018
6 – 9 pm
ARTISANworks
565 Blossom Road
Rochester, NY 14610

Our featured honorees are:

Dr. John J. Condemi
We are pleased to honor Dr. Condemi with our very first John J. Condemi Award for his leading role in anaphylaxis research, treatment and advocacy in the Rochester area.

Continue Reading

EAI Device Incident Sparks Concern on NJ Campus

It’s very sad to learn that public safety officials at Seton Hall University as well as local police officers were so afraid of a lawsuit that they refused to administer epinephrine to a student experiencing anaphylaxis. Fortunately the student’s friend was willing to administer it, as by the time an ambulance arrived it might have been too late. The university now realizes training of public safety officers needs to take place and have been in contact with the Department of Health Services to arrange it. No mention is made of training for the South Orange Police Department.

EAI Device Incident Sparks Concern on NJ Campus

Steton Hall University logo

By Staff Writer Nicholas Kerr
October 3rd, 2018

A Seton Hall University student is alleging her health and safety were put at risk two weeks ago when Public Safety and the South Orange Police Department (SOPD) failed to administer an EpiPen to counter an allergic reaction.

Continue Reading

New Options for Purchasing Auvi-QTM EAI Devices

auvi qGood news for those looking for free epinephrine auto-injectors: Walgreens is partnering with the pharmaceutical company Kaléo to offer AUVI-Q auto-injectors at no cost for commercially insured patients who are eligible for Kaléo's patient support programs. Even those with high deductible plans might be eligible, and if you don’t have insurance, Kaléo may be able to help you through its patient assistance program. The injectors will be delivered right to your home or doctor’s office and have the added benefit of providing audio step-by-step instructions on how to administer them. Check with your doctor and apply today from the link below!

Walgreens and Kaléo Partner to Address Epinephrine Auto-Injector Supply Issues

  • Walgreens becomes the first retail pharmacy to offer access to AUVI-Q auto-injectors at no cost for commercially insured patients who are eligible for Kaléo’s patient support programs.
  • For patients who are unable to fill their current epinephrine prescriptions, Walgreens pharmacists will work with each patient’s healthcare practitioner to see if AUVI-Q is right for them.

Continue Reading

FDA OKs Another Alternative to EpiPen

If you have been concerned about the shortage of epinephrine as well as its rising costs, rest assured help is on the way. In late September 2018, the FDA approved a new low-dose version of Symjepi that is a prefilled injection syringe. For those used to an auto-injector, additional training may be necessary, but the manufacturer claims it is very easy to use. They state the low-dose version will be ready as soon as possible, but the higher dose version that was approved in 2017 is still not available.

FDA OKs Another Alternative to EpiPen

SymjEpi Injector

By Kathleen Doheny
Sept. 27, 2018

On Thursday, the FDA approved a low-dose version of Symjepi, an injected epinephrine to treat life-threatening allergies. The new alternative, when available, may ease ongoing shortages of other epinephrine products such as Epi-Pen.

While the Epi-Pen, and others like Auvi-Q, is an auto-injected device, Symjepi is a prefilled injection syringe, so experts expect it to take time for users to get used to the new device, which aims to prevent the life-threating allergic reaction known as anaphylaxis.

Continue Reading

NY State Senator Tedisco: Police Should be Equipped with EAI Devices

Who is usually the first on the scene in any type of emergency? Law enforcement officials. It may come as a surprise to many that police officers are not allowed to administer epinephrine in an emergency, nor do they carry an EpiPen. New York State Senator Jim Tedisco is working to change this situation, since police officers now carry and administer Narcan for drug overdoses. It would be most helpful if you could email your state senator and representative to tell them of your support of Sen. Tedisco’s legislation, S.9153, to permit law enforcement officers to carry and administer EpiPens.

NY State Senator Tedisco: Police Should be Equipped with EAI Devices

By Wendy Liberatore
August 21, 2018
 
tadesco finalNew York State Senator Jim Tedisco (R-Glenville) has called for legislation to close what he calls a “dangerous loophole” by adding law enforcement, who often are first to respond to emergencies, to the list of professionals who can treat people with life-threatening allergic reactions.

Tedisco wants to enable police officers and members of law enforcement to carry epinephrine auto-injector (EAI) devices to treat people in an emergency.

Continue Reading

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2018 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions